Business · 03/08/1998Updated: 10/17/2026 · 1 min read
FDA Amends Animal Drug Regulations to Reflect Change of Sponsor
Summary
The FDA is updating its regulations to reflect a change in sponsor for an approved new animal drug application, shifting from Ohmeda Pharmaceutical Products Division, Inc. to Baxter Pharmaceutical Products, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →